Omega Healthcare Investors, Inc. — Q2 2023 Form 10-Q Summary
Business context and reporting period
Omega is a healthcare real estate investment trust and UPREIT focused primarily on skilled nursing facilities, assisted living facilities and related healthcare properties in the United States and United Kingdom. The filing covers the three and six months ended June 30, 2023; financial statements are unaudited. At June 30, 2023, the portfolio included 923 healthcare facilities and related investments operated by 71 third-party operators.
Key financial metrics
| Metric | Q2 2023 | Q2 2022 | Six months 2023 | Six months 2022 |
|---|---|---|---|---|
| Total revenue | $250.2 million | $244.6 million | $468.4 million | $494.0 million |
| Net income | $61.5 million | $91.9 million | $98.4 million | $287.1 million |
| Net income available to common stockholders | $59.9 million | $89.5 million | $95.8 million | $279.1 million |
| Diluted EPS | $0.25 | $0.38 | $0.40 | $1.17 |
| Nareit FFO | $155.2 million | $160.6 million | $301.2 million | $331.3 million |
| Net cash from operating activities | — | — | $281.7 million | $305.2 million |
Q2 net margin was approximately 24.6%, compared with 37.6% in the prior-year quarter. Six-month net margin was approximately 21.0%, compared with 58.1% in the prior-year period. The comparison was materially affected by lower asset-sale gains in 2023 and higher impairment and credit-loss charges.
- Revenue composition: Q2 rental income increased to $219.1 million from $211.4 million, while interest income declined to $29.2 million from $31.4 million. Six-month rental income declined to $408.2 million from $428.3 million, and interest income declined to $57.7 million from $62.5 million.
- Expenses: Q2 impairment expense was $21.1 million versus $7.7 million, and the credit-loss provision was $13.0 million versus a $1.6 million recovery. Six-month impairment expense was $60.1 million versus $11.2 million, and the credit-loss provision was $8.9 million versus $0.3 million.
- Cash flow: Six-month operating cash flow was $281.7 million. Investing activities used $184.7 million, primarily reflecting $154.9 million of real estate acquisitions and $182.7 million of loan placements. Financing activities used $41.7 million after $314.8 million of dividends, partly offset by $201.6 million of common stock issuance and a $92.6 million derivative settlement.
- Liquidity: Cash and cash equivalents were $350.7 million, or $356.5 million including restricted cash, at June 30, 2023. Management reported approximately $1.43 billion of availability under the revolving credit facility and $730.5 million of remaining ATM capacity.
- Debt and leverage: Total debt was approximately $5.3 billion, representing approximately 58.3% of total capitalization. The weighted-average debt interest rate was 4.2%, and 99% of debt with outstanding principal had fixed interest payments. The company was in compliance with applicable debt covenants.
- Equity and dividends: Approximately 241.0 million common shares were outstanding at June 30. The company issued 6.5 million shares through its ATM program for $199.4 million of gross proceeds and paid $314.8 million of common dividends during the first six months. The quarterly dividend was $0.67 per share.
Material changes versus the prior comparable period
- Six-month revenue declined 5.2%, while net income available to common stockholders declined 65.7% and Nareit FFO declined 9.1%.
- Asset-sale gains fell to $25.9 million from $138.8 million. Omega sold 12 facilities for $62.3 million of net proceeds in the first six months of 2023, compared with 40 facilities and $386.9 million of proceeds in the prior-year period.
- Higher impairment charges and credit-loss provisions reflected weaker valuations and operator credit conditions. The allowance for credit losses was $185.5 million at June 30, 2023, compared with $144.7 million at June 30, 2022.
- General and administrative expense increased 21.4% for the six-month period, primarily due to higher stock-based compensation, payroll and benefits, and outside services.
- Cash basis operators represented 25.8% of total revenues, excluding write-offs, for the six months ended June 30, down from 32.3% in the prior-year period. However, nine operators deferred $33.6 million of contractual rent and interest during the first six months.
- Omega acquired 11 facilities for approximately $155.0 million during the first six months, with reported initial cash yields between 8.0% and 10.0%, and financed $83.9 million of new real estate loans at a weighted-average rate of 11.6%.
Guidance, outlook, risks and unusual items
Management stated that existing operating cash flow, liquidity, asset sales, loan repayments, equity issuance capacity and revolving-credit availability are expected to fund anticipated needs over the next twelve months. The filing does not provide formal earnings or FFO guidance.
- Operator stress: Labor shortages, elevated wages, inflation, occupancy below pre-pandemic levels and uncertainty over Medicare and Medicaid reimbursement continue to pressure operators. The May 11, 2023 expiration of the federal COVID-19 public health emergency ended certain waivers and began phasing out enhanced Medicaid funding.
- Collectibility and restructurings: LaVie deferred $19.0 million of rent during the first six months and paid $2.5 million in July, a $4.7 million shortfall against rent due. Maplewood short-paid June and July rent by $1.0 million each; Omega applied $2.0 million of security deposits in the third quarter, leaving $2.8 million. Agemo resumed contractual rent payments but its related loans remain on non-accrual status and carry substantial reserves.
- Credit and asset risk: Omega recorded $60.1 million of real estate impairments and maintains significant allowances against real estate and non-real estate loans. A Guardian mortgage settlement resulted in a $35.2 million principal repayment and forgiveness of the remaining $46.8 million of principal, against previously established reserves.
- Financing and interest rates: The company amended its revolving credit facility and term loan from LIBOR to SOFR. It terminated $400 million of forward-starting swaps for a $92.6 million cash settlement and entered into a new $50.0 million interest-rate swap.
- Debt maturity: Omega repaid $350 million of 4.375% senior notes on August 1, 2023 using available cash. A further $400 million of 4.95% senior notes was due in April 2024.
- Legal matters: A securities class-action settlement became effective in May 2023 and was funded by directors’ and officers’ insurers; Omega reversed a previously recorded $31 million legal reserve and related insurance receivable. A separate Gulf Coast subordinated-debt dispute remains subject to litigation and procedural uncertainty.
- Commitments: Remaining commitments totaled $353.7 million, including $230.2 million of construction and capital commitments, $66.7 million of non-real-estate loan commitments and $48.8 million of other real-estate loan commitments.
Most important facts for investors to verify
- Whether operator cash collections, rent deferrals and short-payments improve, particularly for LaVie, Maplewood, Agemo and other cash-basis operators.
- The adequacy of the $185.5 million credit-loss allowance and the potential for additional impairments or loan restructurings.
- Refinancing or repayment plans for the $400 million of senior notes due in April 2024 and the impact of debt costs and credit ratings.
- Whether occupancy, staffing availability, labor costs and government reimbursement rates support operator profitability after the end of COVID-related relief measures.
- The sustainability of dividends and FFO after considering lower asset-sale gains, operator concessions, capital commitments and required debt service.
- The ultimate outcome of the Gulf Coast subordinated-debt litigation and any remaining derivative actions.